56 related articles for article (PubMed ID: 21553705)
41. Summary of the NIH consensus. Helicobacter pylori in peptic ulcer disease.
Md Med J; 1994 Oct; 43(10):923-4. PubMed ID: 7808195
[No Abstract] [Full Text] [Related]
42. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
43. [Clinical significance of Helicobacter pylori infection].
Maev IV; Samsonov AA; Andreev DN; Grechushnikov VB; Korovina TI
Klin Med (Mosk); 2013; 91(8):4-12. PubMed ID: 24437177
[TBL] [Abstract][Full Text] [Related]
44. Role of Helicobacter pylori in gastric pathophysiology--a review.
Kaore SB; Kurhade GA; Phatak MS
Indian J Med Sci; 1997 Nov; 51(11):432-5. PubMed ID: 9567505
[No Abstract] [Full Text] [Related]
45. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.
Strand DS; Kim D; Peura DA
Gut Liver; 2017 Jan; 11(1):27-37. PubMed ID: 27840364
[TBL] [Abstract][Full Text] [Related]
46. Antibiotics in the treatment of peptic ulcer disease.
McKinlay AW
J Antimicrob Chemother; 1992 Feb; 29(2):92-6. PubMed ID: 1506343
[No Abstract] [Full Text] [Related]
47. Treatment Approach of Refractory
Cortés P; Nelson AD; Bi Y; Stancampiano FF; Murray LP; Pujalte GGA; Gomez V; Harris DM
J Prim Care Community Health; 2021; 12():21501327211014087. PubMed ID: 33949229
[No Abstract] [Full Text] [Related]
48. Potent acid inhibition: summary of the evidence and clinical application.
Mearin F; Ponce J
Drugs; 2005; 65 Suppl 1():113-26. PubMed ID: 16335865
[No Abstract] [Full Text] [Related]
49. Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition.
Joo MK; Park CH; Kim JS; Park JM; Ahn JY; Lee BE; Lee JH; Yang HJ; Cho YK; Bang CS; Kim BJ; Jung HK; Kim BW; Lee YC;
Gut Liver; 2020 Nov; 14(6):707-726. PubMed ID: 33191311
[TBL] [Abstract][Full Text] [Related]
50. [Current therapy of Helicobacter pylori infection in peptic ulcer disease (second part)].
Boixeda de Miquel D; Martín de Argila C
Rev Clin Esp; 2002 Oct; 202(10):546-8. PubMed ID: 12361554
[No Abstract] [Full Text] [Related]
51. An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass.
Carr WR; Mahawar KK; Balupuri S; Small PK
Obes Surg; 2014 Sep; 24(9):1520-7. PubMed ID: 24851857
[TBL] [Abstract][Full Text] [Related]
52. Peptic ulcers. Stopping them for good.
Mayo Clin Health Lett; 2011 Mar; 29(3):1-3. PubMed ID: 21553705
[No Abstract] [Full Text] [Related]
53. [NSAID-gastropathy and Helicobacter pylori: more questions than answers].
Shirinskaia NV; Akhmedov VA
Eksp Klin Gastroenterol; 2010; (9):116-20. PubMed ID: 21427936
[TBL] [Abstract][Full Text] [Related]
54. Management of Helicobacter pylori infection.
Costa F; D'Elios MM
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
[TBL] [Abstract][Full Text] [Related]
55. Drugs for peptic ulcer disease and GERD.
Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
[No Abstract] [Full Text] [Related]
56. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
Howden CW; Leontiadis GI
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
